Ocrevus

Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Fierce Pharma
Wed, 04/17/24 - 11:33 am
Roche
Ocrevus
MS
multiple sclerosis
AAN
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Fierce Pharma
Wed, 10/11/23 - 10:07 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Phase III trial results bring subcutaneous Ocrevus closer to its potential approval
Clinical Trials Arena
Mon, 07/31/23 - 10:09 am
Roche
Ocrevus
clinical trials
MS
multiple sclerosis
Roche eyes alternate mode of administration for Ocrevus in MS
Clinical Trials Arena
Thu, 07/13/23 - 10:21 am
Roche
Ocrevus
clinical trials
MS
multiple sclerosis
Roche’s Ocrevus Shines in Relapsing-Remitting MS, Safety Studies
BioSpace
Thu, 11/3/22 - 07:28 pm
Genentech
Roche
Ocrevus
MS
Relapsing Remitting Multiple Sclerosis
Roche delays DMD drug deadline, decides to rejig MS trials because of Ukraine war
Fierce Biotech
Tue, 04/26/22 - 10:33 am
Roche
Ocrevus
clinical trials
Duchenne Muscular Dystrophy
Roche posted a big Q1 sales gain. So why is the company expecting a slowdown later this year?
Fierce Pharma
Mon, 04/25/22 - 10:47 am
Roche
earnings
COVID-19
Ocrevus
diagnostics
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Endpoints
Fri, 04/16/21 - 09:57 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis
To challenge Ocrevus, German Merck takes on Aubagio
EP Vantage
Sun, 02/23/20 - 02:00 pm
Ocrevus
Merck KGaA
Aubagio
evobrutinib
MS
multiple sclerosis
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
ECTRIMS: Roche's Ocrevus, given early, cuts wheelchair risk by 42%
Fierce Pharma
Sun, 09/15/19 - 09:59 pm
Roche
Ocrevus
multiple sclerosis
Novartis takes aim at Roche's star MS drug
Reuters
Fri, 08/30/19 - 10:08 am
Novartis
Roche
multiple sclerosis
Arzerra
ofatumumab
Ocrevus
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Genentech
Roche
Ocrevus
Novartis
siponimod
FDA
MS
multiple sclerosis
Roche unveils long-term data from MS blockbuster Ocrevus
Pharmaforum
Wed, 10/10/18 - 10:24 am
Roche
Ocrevus
relapsing multiple sclerosis
MS
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
Mon, 09/10/18 - 12:16 am
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
Fierce Pharma
Wed, 06/6/18 - 09:32 pm
Roche
MS
multiple sclerosis
Ocrevus
FDA
vaccines
Ocrevus fuels fast start to year for Roche
Biopharma Dive
Thu, 04/26/18 - 07:21 pm
Roche
earnings
Ocrevus
Most Impressive Drug Launch: Roche's Ocrevus
BioPharma Dive
Mon, 12/4/17 - 11:41 am
Roche
Ocrevus
drug launches
MS
multiple sclerosis

Pages